Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Hyperpolarized 13C lactate, pyruvate, and alanine: noninvasive biomarkers for prostate cancer detection and grading.

Albers MJ, Bok R, Chen AP, Cunningham CH, Zierhut ML, Zhang VY, Kohler SJ, Tropp J, Hurd RE, Yen YF, Nelson SJ, Vigneron DB, Kurhanewicz J.

Cancer Res. 2008 Oct 15;68(20):8607-15. doi: 10.1158/0008-5472.CAN-08-0749.

2.

Hyperpolarized 13C MR for molecular imaging of prostate cancer.

Wilson DM, Kurhanewicz J.

J Nucl Med. 2014 Oct;55(10):1567-72. doi: 10.2967/jnumed.114.141705. Epub 2014 Aug 28. Review.

3.

Tumor imaging using hyperpolarized 13C magnetic resonance spectroscopy.

Brindle KM, Bohndiek SE, Gallagher FA, Kettunen MI.

Magn Reson Med. 2011 Aug;66(2):505-19. doi: 10.1002/mrm.22999. Epub 2011 Jun 9. Review.

4.

The use of dynamic nuclear polarization (13)C-pyruvate MRS in cancer.

Gutte H, Hansen AE, Johannesen HH, Clemmensen AE, Ardenkjær-Larsen JH, Nielsen CH, Kjær A.

Am J Nucl Med Mol Imaging. 2015 Oct 12;5(5):548-60. eCollection 2015. Review.

5.

Prediction of Cancer Treatment Response by Physiologic and Metabolic Imaging.

Matsumoto S.

Yakugaku Zasshi. 2016;136(8):1101-5. doi: 10.1248/yakushi.15-00234-5. Review. Japanese.

6.
7.

Lactate transporters in the context of prostate cancer metabolism: what do we know?

Pértega-Gomes N, Baltazar F.

Int J Mol Sci. 2014 Oct 13;15(10):18333-48. doi: 10.3390/ijms151018333. Review.

8.

Lactate - A new frontier in the immunology and therapy of prostate cancer.

Nenu I, Gafencu GA, Popescu T, Kacso G.

J Cancer Res Ther. 2017 Jul-Sep;13(3):406-411. doi: 10.4103/0973-1482.163692. Review.

9.

NMR-based metabolomics of prostate cancer: a protagonist in clinical diagnostics.

Kumar D, Gupta A, Nath K.

Expert Rev Mol Diagn. 2016 Jun;16(6):651-61. doi: 10.1586/14737159.2016.1164037. Epub 2016 Mar 25. Review.

PMID:
26959614
10.

Novel Approaches to Imaging Tumor Metabolism.

Tee SS, Keshari KR.

Cancer J. 2015 May-Jun;21(3):165-73. doi: 10.1097/PPO.0000000000000111. Review.

11.

Potential of Induced Metabolic Bioluminescence Imaging to Uncover Metabolic Effects of Antiangiogenic Therapy in Tumors.

Indraccolo S, Mueller-Klieser W.

Front Oncol. 2016 Feb 1;6:15. doi: 10.3389/fonc.2016.00015. eCollection 2016. Review.

12.

Potential Clinical Roles for Metabolic Imaging with Hyperpolarized [1-(13)C]Pyruvate.

Serrao EM, Brindle KM.

Front Oncol. 2016 Mar 11;6:59. doi: 10.3389/fonc.2016.00059. eCollection 2016. Review. No abstract available.

Supplemental Content

Support Center